![]() |
![]() |
Legal status
Patent revoked (after opposition at EPO)
(51) | INT.CL. | C12N 15/63 | (2006.01) |
(11) | Number of the document | 3066201 |
(13) | Kind of document | T |
(96) | European patent application number | 14802772.5 |
Date of filing the European patent application | 2014-11-07 | |
(97) | Date of publication of the European application | 2016-09-14 |
(45) | Date of publication and mention of the grant of the patent | 2018-03-07 |
(46) | Date of publication of the claims translation | 2018-08-10 |
(86) | Number | PCT/US2014/064663 |
Date | 2014-11-07 |
(87) | Number | WO 2015/070083 |
Date | 2015-05-14 |
(30) | Number | Date | Country code |
201361901215 P | 2013-11-07 | US |
(72) |
PALESTRANT, Deborah, US
MATA-FINK, Jordi, US
BORISY, Alexis, US
ZHANG, Feng, US
DAVIDSON, Beverly, US
RODRIGUEZ, Edgardo, US
|
(73) |
Editas Medicine, Inc. ,
11 Hurley Street, Cambridge, MA 02141,
US
The Broad Institute, Inc. , 415 Main Street, Cambridge, MA 02142, US Massachusetts Institute of Technology , 77 Massachusetts Avenue, Cambridge, MA 02139, US The University of Iowa Research Foundation , 112 N. Capitol Street 6 Gilmore Hall, Iowa City IA 52242-5500, US |
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Su CRISPR susiję būdai ir kompozicijos su valdančiomis gRNR |
CRISPR-RELATED METHODS AND COMPOSITIONS WITH GOVERNING GRNAS |
Payment date | Validity (years) | Amount | |
2023-10-19 | 10 | 231.00 EUR |
Patent revoked (after opposition at EPO) | ||
Invalidation date | 2024-04-26 |